Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats.

Published

Journal Article

Smoking cessation strategies are of prime medical importance. Despite availability of various pharmacological agents in combating addiction to nicotine, more effective medications are needed. Based on recent findings, the glutamatergic system in the brain may provide novel targets. Here, we evaluated the effects of acute administration of sub-anesthetic doses of ketamine, an NMDA receptor antagonist, in both male and female Sprague-Dawley rats trained to self-administer nicotine. Animals were injected subcutaneously with 5, 7.5 and 10 mg/kg ketamine or saline and the effects on the number of intravenous nicotine infusions during a 45 min session was measured. Ketamine treatment significantly reduced nicotine self-administration in a dose-dependent manner. Moreover, a differential sensitivity between the sexes was observed as male rats responded to a lower dose of ketamine and with higher magnitude of effect than female rats. It is concluded that glutamatergic receptor manipulations may offer a novel and potentially sex-dependent intervention in nicotine addiction.

Full Text

Duke Authors

Cited Authors

  • Rezvani, AH; Tizabi, Y; Slade, S; Getachew, B; Levin, ED

Published Date

  • March 6, 2018

Published In

Volume / Issue

  • 668 /

Start / End Page

  • 98 - 102

PubMed ID

  • 29339170

Pubmed Central ID

  • 29339170

Electronic International Standard Serial Number (EISSN)

  • 1872-7972

Digital Object Identifier (DOI)

  • 10.1016/j.neulet.2018.01.022

Language

  • eng

Conference Location

  • Ireland